Congress has been slow in attempts to reverse recent adverse changes to IRS Section 174, which is preventing American businesses from fully deducting their R&D costs in a timely fashion. While revisions quickly moved through the House, the U.S. Senate has been slow to take up the changes that cost manufacturers six to seven figure-increases in tax liability. 4/25/2024